Active Pharmaceutical Ingredient (API)
Gefitinib
EGFR Tyrosine Kinase Inhibitor
A targeted drug used for Non-Small Cell Lung Cancer ($\text{NSCLC}$). It selectively inhibits the tyrosine kinase activity of the Epidermal Growth Factor Receptor ($\text{EGFR}$), which is overexpressed in certain lung carcinomas.
Technical Profile
- Reference Code
- GEF612
- CAS Number
- 184475-35-2
- Molecular Weight
- 446.90 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C22H24ClFN4O3
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Gefitinib as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||